Majid Sasanpour, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 181 Franklin Ave, Nutley, NJ 07110 Phone: 973-667-8117 Fax: 973-667-6642 |
News Archive
Galapagos NV announced today that it has started a Phase II clinical study for the Company's flagship program GLPG0259, a novel drug being developed for rheumatoid arthritis. In this clinical trial, the safety and efficacy of this novel candidate drug will be tested in RA patients. Galapagos plans to announce interim results by the middle of next year and complete the trial by the end of 2011.
Although it is still challenging to prevent the transmission of COVID-19, researchers at the University of Miami are using all the strategies they can to fend off the spread.
Scientists have found that a synthetic molecule they designed can block activation of a gene in liver cancer cells, halting a process that allows some of those cancer cells to survive chemotherapy.
According to the latest survey, premiums for employer-sponsored health insurance continued to escalate this year even as the share of workers getting less generous coverage reached a new high.
In a study of adults with rheumatoid arthritis, those who were severely obese experienced more rapidly progressing disability than patients who were overweight.
› Verified 7 days ago